Imaging Tumor Necrosis with Ferumoxytol.
Ultra-small superparamagnetic iron oxide nanoparticles (USPIO) are promising contrast agents for magnetic resonance imaging (MRI). USPIO mediated proton relaxation rate enhancement is strongly dependent on compartmentalization of the agent and can vary depending on their intracellular or extracellul...
Main Authors: | Maryam Aghighi, Daniel Golovko, Celina Ansari, Neyssa M Marina, Laura Pisani, Lonnie Kurlander, Christopher Klenk, Srabani Bhaumik, Michael Wendland, Heike E Daldrup-Link |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4646285?pdf=render |
Similar Items
-
Implementing total-dose ferumoxytol in lieu of split-dose ferumoxytol
by: Au, L., et al.
Published: (2021) -
The ferumoxytol in renal insufficiency study (FiRST)
by: Vemulapalli Sreekanth, et al.
Published: (2013-01-01) -
Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles
by: Heike E. Daldrup-Link MD, PhD
Published: (2017-09-01) -
The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
by: Iain C. Macdougall, et al.
Published: (2017-04-01) -
Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell ‘don't eat me’ signals off and ‘eat me’ signals on
by: Suchismita Mohanty, et al.
Published: (2019-10-01)